Industry Press Releases

$29.99 Billion Lung Cancer Surgery Market by Procedure & Device - Global Forecast to 2021 - Driven by Increasing Lung Cancer Awareness Campaigns - Research and Markets

Monday, Feb 06, 2017
Pressreleases

Research and Markets has announced the addition of the "Lung Cancer Surgery Market by Procedure and Device - Global Forecast to 2021" report to their offering.

 The lung cancer surgery market is projected to reach USD 29.99 Billion by 2021 from USD 21.58 Billion in 2016, at a CAGR of 6.8% from 2016 to 2021. The high incidence and prevalence of lung cancer and rise in healthcare expenditure, increasing lung cancer awareness campaigns, and technological advancements in the lung cancer treatment are the major factors fueling the growth of this market.

The global lung cancer surgery market is segmented based on device, procedure, and region. On the basis of device, the lung cancer surgery market is segmented into surgical instruments, monitoring and visualizing systems, and endosurgical equipment. The monitoring and visualizing systems segment is expected to register the highest CAGR during the forecast period. Increasing awareness about advanced treatment procedures such as video-assisted thoracoscopic surgeries (VATS) and laser surgeries are the factors driving the growth of this segment.

On the basis of procedure, the lung cancer surgery market is classified into thoracotomy and minimally invasive surgeries. The thoracotomy segment further sub segmented into lobectomy, sleeve resection, segmentectomy, and pneumonectomy. In 2016, the thoracotomy segment is expected to account for the largest share of the global lung cancer surgery. These surgeries are widely adopted to confirm the diagnosis of lung cancer, remove tumours and scar tissue, or fix air leaks.

The major factors contributing to the growth of the global lung cancer surgery market include the increasing incidence and prevalence of cancer, increasing lung cancer awareness campaigns, and rising aging population. On the other hand, high cost of lung cancer surgery is restraining the growth of this market. The high growth potential in the Asian region provides opportunities for players in the lung cancer surgery market.

Companies Mentioned:

    Accuray Incorporated
    Ackermann Instrumente GmbH
    Angiodynamics Inc.
    Ethicon Us, LLC (Johnson & Johnson)
    Intuitive Surgical Inc.
    Karl Storz GmbH
    Olympus Corporation
    Scanlan International, Inc.
    Teleflex Incorporated
    Trokamed GmbH

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights

5 Market Overview

6 Lung Cancer Surgical Devices Market, By Type

7 Lung Cancer Surgical Procedures Market, By Type

8 Lung Cancer Surgery Market, By Region

9 Lung Cancer Surgical Devices Market, Competitive Landscape

10 Company Profiles

For more information about this report visit http://www.researchandmarkets.com/research/dssxxp/lung_cancer
Contacts

Research and Markets
Laura Wood, Senior Manager

press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

 

Source:businesswire.com

Other Press Releases